Coverage policy for transplant rejection monitoring establishes a simplified and accelerated pathway for Medicare coverage of Chronix’s solid organ transplant rejection monitoring test Oncocyte’s ...

(RTTNews) - The U.S. Food and Drug Administration has granted orphan drug designation to riliprubart for the investigational treatment of antibody-mediated rejection (AMR) in solid organ ...

Ongoing phase 2 study evaluating riliprubart for the potential prevention and treatment of active antibody-mediated rejection in kidney transplant recipients Riliprubart was also designated orphan ...

CHICAGO & TAIPEI, Taiwan--(BUSINESS WIRE)--Taiwan Bio and TRACT Therapeutics are pleased to announce a new strategic partnership to advance a cellular therapy to revolutionize the prevention of ...

Antibody-mediated rejection (AMR) presents a major barrier to long-term success in solid organ transplantation. This process is characterised by recipient-derived antibodies targeting donor antigens, ...

If an organ in your body (such as the heart, kidneys, or liver) is not working well enough because of an illness or injury, you may need an organ transplant. An organ transplant involves surgically ...

WASHINGTON -- Heart transplant patient Eddie Garcia was "feeling like a million bucks" one day in the summer of 2021. He had just gotten back from a 3-mile walk, something he couldn't do prior to his ...

Once a transplant patient gets past the first week to three months with their new organ, the risk of rejection drops substantially—at least for the first year. But over time, the immunosuppressants ...

Nantes, France, April 27, 2026 – 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today welcomes the announcement by its partner Veloxis Pharmaceuticals, Inc. that the U.S.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Nearly 10% of solid organ transplant recipients may ...